Study Finds No Evidence of Harm From GLP-1 Exposure During Pregnancy

Study finds no evidence of harm from GLP-1 exposure during pregnancy

Women who accidentally become pregnant while taking a GLP-1 treatment for diabetes or weight loss are not at increased risk of miscarriage or other complications of pregnancy, according to new research.

Using weight loss jabs in pregnancy is safe, major study suggests

Women can continue to safely use weight loss jabs when trying to conceive without putting their baby at risk, a major new study has suggested.

expert reaction to a systematic review and meta-analysis looking at preconception, pregnancy, and postnatal use of GLP-1 RAs in women with diabetes

Scientist comment on a systemic review and meta-analysis, published in The Lancet Obstetrics, Gynaecology & Women’s Health, looking at preconception, pregnancy, and postnatal use of GLP-1 RAs in women with diabetes.   Dr Nerys Astbury, Associate Professor – Diet & Obesity, Nuffield Department of Primary Health Care Sciences, University of Oxford, said: “This is an interesting and much-needed review, particularly given the rapidly increasing use …

Study finds reassuring signs for diabetic and weight loss drug use around pregnancy, but questions remain

A study by an international group of researchers finds popular diabetes and weight-loss drugs are not linked to pregnancy complications in most women with diabetes. The results of the study have just been published in [...] The post Study finds reassuring signs for diabetic and weight loss drug use around pregnancy, but questions remain appeared first on .